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1. Specific Aims 
The goals of this proposal are three-fold. First, the study will address the hypothesis that 
equations can be derived from basic fluid mechanic principles to quantify regurgitant volume using 
quantities that can be directly measured by Doppler. Second, these basic physical principles can 
be used to interpret color flow mapping variability related to regurgitant jet behavior in the presence 
of solid structures or interrupting flows. Third, additional variability inherent to measurement 
technique (i.e. instrument settings) will be addressed. 
To achieve these objectives, the following specific aims are proposed: 1) to derive 
equations from the principles of turbulent jet flow and conservation of mass which provide orifice 
flow rate, and therefore regurgitant volume, as a function of Doppler measurable quantities; 2) in 
in vitro models, to test the accuracy of the equations in predicting actual regurgitant volume; 3) to 
define in an in vitro model, the relationship between regurgitant flow, and spatial characteristics of 
the color flow jet, namely, jet length, width, area, and volume; 4) in in vitro models, to address the 
variability in these relationships due to machine settings, driving pressure, and physiologically 
observed jet flow phenomena, namely, the Coanda effect, impingement, counterflow, and coflow; 
and 5) to investigate the applicability of the quantitation techniques to various designs of heart 
valve prostheses. 
These comprehensive studies are performed in vitro in order to allow precise and 
independent control of all variables. In vivo studies, while providing realistic environments, do not 
generally allow independent control of variables such as is required for such fundamental studies. 
Careful design of flow models provides semi-realistic environments, while allowing dependent 
control. 
2. Studies and Results 
A. CONSERVATION OF MOMENTUM TECHNIQUE APPLIED TO REGURGITANT 
JETS 
The purpose of this study was to determine whether the inverse relationship of centerline 
velocity to distance develops sufficiently rapidly so that quantitative techniques based on that decay 
would be applicable over a wide range of heart rates. Two different techniques, an engineering 
tool, laser Doppler anemometry, and a clinical tool, Doppler ultrasound, were used for measuring 
jet centerline velocities (averaged over multiple beats). Physiologic pulsatile flows were pumped 
through two circular orifices, 4 and 6 mm in diameter, at 60 to 150 beats/min; peak orifice 
velocities ranged from 2 to 5 m/sec. Steady flow experiments were also performed with the same 
orifice diameters and over the same velocity range. Peak centerline velocities in the fully 
developed turbulent jet region decayed inversely with distance at all heart rates studies. With laser 
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Doppler anemometry, the proportionality constant of the decay curve was found to be in the range 
6.4 ± 0.5. The pulsed Doppler results provided a jet constant in the range 6.7 ± 0.3 with the 4-mm 
orifice diameter, whereas the constant was 6.5 ± 0.3 with the 6-mm orifice diameter. In steady 
flow, the proportionality constant was found to be 6.1 ± 0.2. Therefore, within a wide range of 
physiologic heart rates, full jet development occurs with sufficient speed so that the expected 
centerline velocity decay is established (jet empirical constant of 6.3). The conservation of 
momentum technique for calculating orifice flow rate on the basis of these centerline velocities is 
thus applicable under physiologic conditions. 
B. EFFECT OF COUNTER AND CO-FLOWS ON REGURGITANT JETS 
The purpose of this study was to address the hypothesis that physiologic counterflow field 
may influence regurgitant jet size. Steady flow was driven through 0.02-.12 cm2 circular orifices 
at .5-5 m/s. At a constant orifice velocity and flow rate, the velocity of a uniform counterflow field 
was varied from 1 to 8 cm/s. Jet penetration length was measured by fluorescent dye visualization 
in 10 videoframes to average out turbulent fluctuations. Despite its relatively low velocities, 
counterflow dramatically curtailed jet length. For example, the length of a 1.8 m/s jet (.05 cm2 
orifice) decreased from 20 to 10 cm as counterflow velocity increased from 3 to 7.5 cm/s. Jet 
length decreased as the ratio of counterflow to jet momentum increased, but with a nonlinear 
relationship: length declined steeply for low-momentum jets (momentum ratio < 1.0) and with a 
more shallow slope for high-momentum jets (ratio > 1.0). Counterflow fields analogous to atrial 
inflow have an important effect on the length of regurgitant jets. Low-momentum jets, such as 
TR, are more sensitive to counterflow, while high-momentum jets, such as significant MR, are 
less sensitive. Further studies have also shown that wall jets in a counterflow are uniformly longer 
than center jets (up to 40% longer for jets of high momentum). 
C. PROXIMAL FLOW CONVERGENCE STUDIES 
Recent studies have shown that the flow convergence region proximal to an orifice can be 
used to quantify flow rate by Doppler flow mapping. Clinically, however, flow may converge 
toward aortic or mitral regurgitant orifices over a 3-dimensional (3D) or conical angle. Therefore, 
we tested the hypothesis that calculating orifice flow rate requires that the 3D angle of approach be 
taken into account. Steady flow (1-3 1/min) was pumped through circular orifices in an upright 
and inverted 90° cone and flow rate was calculated with and without the 3D angle factor. Flow 
rates calculated assuming a hemispherical convergence region underestimated actual values by 46 
± 4% for the upright cone and overestimated them by 230 ± 26% for the inverted cone. 
Correcting for the 3D angle gave values within 5% of actual ones (r=.98, SEE=.13 1/min). 
Application of the proximal convergence method for flow through restrictive orifices must take 
into account the three-dimensional angle determined by the surrounding leaflets. 
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D. CONFINED AND IMPINGING JETS 
The distal jet centerline velocity technique, previously described was tested on pure 
confined, pure impinging and confined impinging jets. When the distance between the orifice and 
the impinging wall becomes relatively small, in addition to the confinement created by the side 
walls, it may be hypothesized that the jet momentum is no longer conserved. Physiologic pulsatile 
flow as pumped through circular orifices (2-4 mm) at 70-150 beats/min in two receiving chambers 
(51 and 88 mm in diameter); at each heart rate, peak velocity was varied from 2-5 m/s, and the 
orifice-to-end wall spacing was varied from 30-93 mm. Centerline velocities were recorded by 
echo Doppler, averaged over multiple beats over a wide physiologic range of heart rates, and 
sufficient distance from the back wall, full jet development occurs with sufficient speed so that the 
expected centerline velocity decay curve is established at peak flow. The conservation of 
momentum technique for calculating orifice flow rate based on these centerline velocities should 
therefore be applicable at reasonable orifice-to-end wall spacings. 
E. COMPUTER SIMULATION STUDIES 
Despite a series of studies showing variability in color Doppler jet areas (CJA) due to 
factors other than regurgitant flow rate, such measurements are still the best available non-invasive 
markers of the severity of regurgitation in the clinical setting. To rigorously explore factors 
affecting jet size, a computer model was developed which simulates color Doppler jets for relevant 
physiologic and technical inputs. The computer model allows rigorous testing of factors affecting 
jet size to an extent not available in vitro or in vivo. Such detailed studies will aid new experimental 
designs and potentially lead to new quantitation techniques. 
3. 	Significance 
During the past year we have continued to validate that fundamental engineering (fluid 
mechanic) principals can be applied to study and quantitate valvular regurgitation. The results of 
our studies will be valuable to cardiologists as they attempt to use echo Doppler techniques to non-
invasively quantitate valvular regurgitation in their patients. 
The free jet studies clearly demonstrated that the conservation of momentum technique is 
applicable to regurgitant jets that occur in vivo. The counterflow work showed that the jet length 
and area measurements currently used in clinical practice are flawed and could lead to erroneous 
interpretation of the severity of tricuspid and mitral regurgitation. 
The computer model demonstrated the value of computer simulation studies in reducing 
the need for costly and time consuming in vitro and in vivo experimental/clinical studies. 
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4. Plans 
No changes to plans originally purposed. 
(i) Detailed pulsatile flow studies will be conducted on central and wall jets in counter 
and co-flowing environments. 
(ii) Pulsatile flow studies to test the validity of the proximal flow convergence 
technique to quantitate regurgitant volume. 
(iii) Begin studies to investigate the effects of receiving chamber compliance. 
(iv) Conduct steady flow studies on prosthetic heart valves, to study the applicability of 
the distal jet and proximal flow convergence techniques, to quantitate prosthetic 
valve regurgitation. 
(v) Write journal articles based on the results of the studies conducted during the first 
two years of the project. 
S. 	Human Subjects 
N/A 
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